Predict your next investment

Ben Franklin Technology Partners company logo
Venture Capital

Investments

63

Portfolio Exits

1

Funds

1

Partners & Customers

1

About Ben Franklin Technology Partners

Ben Franklin Technology Partners is a technology-based economic development program. The company primarily focuses on investing in and linking early-stage technology firms and established manufacturers with experts, universities, follow-on funding, and other resources to help them prosper through innovation. It primarily serves the technology and manufacturing industries. It was founded in 1982 and is based in Harrisburg, Pennsylvania.

Headquarters Location

1010 North Seventh Street Suite 307

Harrisburg, Pennsylvania, 17102,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Ben Franklin Technology Partners Investments

63 Investments

Ben Franklin Technology Partners has made 63 investments. Their latest investment was in Vittoria Biotherapeutics as part of their Unattributed VC on January 01, 2026.

CBI Logo

Ben Franklin Technology Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/1/2026

Unattributed VC

Vittoria Biotherapeutics

$14.89M

Yes

Agent Capital, BioAdvance, Hatch Biofund, Tellus BioVentures, and Undisclosed Angel Investors

5/29/2025

Seed VC - II

Alloy

$1.42M

No

3

11/5/2024

Series A

CollX

$10M

No

114 Ventures, Bobby Witt Jr, Brand Foundry Ventures, FJ Labs, Next Coast Ventures, and Robert Andrew Witt Jr.

4

10/15/2024

Seed VC

Subscribe to see more

$XXM

Subscribe to see more

10

9/6/2024

Seed VC

Subscribe to see more

$XXM

Subscribe to see more

10

Date

1/1/2026

5/29/2025

11/5/2024

10/15/2024

9/6/2024

Round

Unattributed VC

Seed VC - II

Series A

Seed VC

Seed VC

Company

Vittoria Biotherapeutics

Alloy

CollX

Subscribe to see more

Subscribe to see more

Amount

$14.89M

$1.42M

$10M

$XXM

$XXM

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Agent Capital, BioAdvance, Hatch Biofund, Tellus BioVentures, and Undisclosed Angel Investors

114 Ventures, Bobby Witt Jr, Brand Foundry Ventures, FJ Labs, Next Coast Ventures, and Robert Andrew Witt Jr.

Sources

3

4

10

10

Ben Franklin Technology Partners Portfolio Exits

1 Portfolio Exit

Ben Franklin Technology Partners has 1 portfolio exit. Their latest portfolio exit was SessionGuardian on December 10, 2024.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2024

Acquired

$XXM

2

Date

12/10/2024

Exit

Acquired

Companies

Valuation

$XXM

Acquirer

Sources

2

Ben Franklin Technology Partners Fund History

1 Fund History

Ben Franklin Technology Partners has 1 fund, including Global Opportunity Pennsylvania (GO PA) Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/10/2023

Global Opportunity Pennsylvania (GO PA) Fund II

$28M

1

Closing Date

11/10/2023

Fund

Global Opportunity Pennsylvania (GO PA) Fund II

Fund Type

Status

Amount

$28M

Sources

1

Ben Franklin Technology Partners Partners & Customers

1 Partners and customers

Ben Franklin Technology Partners has 1 strategic partners and customers. Ben Franklin Technology Partners recently partnered with SnapHealth on April 4, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

4/1/2021

Partner

United States

Date

4/1/2021

Type

Partner

Business Partner

Country

United States

News Snippet

Sources

Ben Franklin Technology Partners Team

1 Team Member

Ben Franklin Technology Partners has 1 team member, including current Managing Director, Omar Mencin.

Name

Work History

Title

Status

Omar Mencin

GO Philly Fund, US Market Access Center, and Goldman Sachs

Managing Director

Current

Name

Omar Mencin

Work History

GO Philly Fund, US Market Access Center, and Goldman Sachs

Title

Managing Director

Status

Current

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.